Newgen Software Technologies announced the approval of its unaudited standalone and consolidated financial results for Q2 FY26. The board also approved the issuance and allotment of equity shares under the Newgen ESOP Scheme 2022 & 2014. A total of 539,000 and 100,000 equity shares were allotted under the 2022 and 2014 schemes respectively. The board meeting was held on October 28, 2025.
Financial Performance for Q2 FY26
The Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. These results were reviewed in a board meeting held on October 28, 2025.
Equity Shares Allotment
The Board approved the issuance and allotment of equity shares under the company’s ESOP schemes:
- Newgen ESOP Scheme 2022: 539,000 equity shares of face value ₹10 each were allotted to the Newgen ESOP Trust.
- Newgen ESOP Scheme 2014: 100,000 equity shares of face value ₹10 each were allotted to the Newgen ESOP Trust.
Following this allotment, the paid-up share capital of the company has increased from ₹1,41,67,87,870 to ₹1,42,31,77,870.
Consolidated Financial Highlights (₹ in Lakhs)
- Revenue from operations: ₹40,079.35 for Q2 FY26 compared to ₹36,115.75 for Q2 FY25.
- Profit before tax: ₹10,533.54 for Q2 FY26 compared to ₹9,257.55 for Q2 FY25.
- Net profit for the period: ₹8,174.24 for Q2 FY26 compared to ₹7,033.17 for Q2 FY25.
Standalone Financial Highlights (₹ in Lakhs)
- Revenue from operations: ₹36,618.07 for Q2 FY26 compared to ₹33,127.48 for Q2 FY25.
- Profit before tax: ₹9,830.47 for Q2 FY26 compared to ₹8,677.87 for Q2 FY25.
- Net profit for the period: ₹7,669.14 for Q2 FY26 compared to ₹6,586.71 for Q2 FY25.
Source: BSE
